デフォルト表紙
市場調査レポート
商品コード
1667687

薬剤コーティングバルーンの世界市場:2025年

Drug-Coated Balloons Global Market Report 2025


出版日
ページ情報
英文 200 Pages
納期
2~10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
薬剤コーティングバルーンの世界市場:2025年
出版日: 2025年02月28日
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

薬剤コーティングバルーンの市場規模は今後数年で急成長が見込まれます。CAGR 15.6%で推移し、2029年には22億2,000万米ドルに成長すると予測されています。

予測期間の成長の背景には、高齢者人口の増加、適応症と用途の拡大、外来および外来医療への注力、ドラッグデリバリーのイノベーションとの統合、世界的な健康へのイニシアチブなどがあります。予測期間の主な動向には、新製剤の規制承認、副作用の最小化重視、生体吸収性コーティングの出現、新興国での市場拡大、患者中心のアプローチなどがあります。

冠動脈疾患 (CAD) の有病率の増加が、今後の薬剤コーティングバルーン市場の成長を牽引すると予測されています。薬剤コーティングバルーンは、CADの治療に使用される医療機器であり、血管形成術後に動脈が再び狭くなる再狭窄を防ぐために、手術中に動脈内に薬剤を放出します。2022年8月にJournal of the American College of Cardiologyに掲載された研究によると、4つの心血管危険因子すべてが、2025年から2060年にかけて米国の一般人口の間で増加すると予想されています。糖尿病が39.3%と最も大きく増加し、次いで脂質異常症が27.6%、高血圧が25.1%、肥満が18.3%と予測されています。さらに、心不全 (33.4%) と虚血性心疾患 (30.7%) の割合が、心筋梗塞 (16.9%) と脳卒中 (33.8%) とともに最も大きく増加すると予測されています。これらのことから、CADの有病率の上昇が薬剤コーティングバルーン市場を押し上げると予想されています。

外来手術センターの増加も、薬剤コーティングバルーン市場の成長を促進すると予想されます。外来手術センター (ASC) は、一晩の入院を必要としない外科手術を専門に行う医療施設です。薬物コーティングバルーンは、標準的なバルーンに比べて処置時間が短縮されるため、ASCで重要な役割を果たしています。VMG Healthは2023年9月に、Medicare認定外来手術センターの総数が2021年の1,752施設から、2022年には1,804施設に2.9%増加したと報告しています。これらのことから、外来手術センターの普及拡大も薬剤コーティングバルーン市場拡大の原動力となっています。

当レポートでは、世界の薬剤コーティングバルーンの市場を調査し、市場概要・特徴、主要動向、市場影響因子の分析、市場規模の推移・予測、各種区分・地域/主要国別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 エグゼクティブサマリー

第2章 薬剤コーティングバルーン市場:特徴

第3章 薬剤コーティングバルーン市場:動向・戦略

第4章 薬剤コーティングバルーン市場:マクロ経済シナリオ (金利、インフレ、地政学、COVID-19とその回復が市場に与える影響を含む)

第5章 世界の薬剤コーティングバルーン市場:成長分析・戦略分析フレームワーク

  • PESTEL分析・成長推進因子/阻害因子
  • エンドユーザー産業の分析
  • 市場成長率の分析
  • 市場規模の推移・成長率
  • 市場規模の成長予測
  • TAM (Total Addressable Market) 市場

第6章 薬剤コーティングバルーン市場:セグメンテーション

  • 市場規模の推移・予測:製品別
  • 末梢動脈疾患に対する薬剤コーティングバルーン
  • CAD用薬剤コーティングバルーン
  • その他の適応症のための薬剤コーティングバルーン
  • 市場規模の推移・予測:薬剤タイプ別
  • パクリタキセル
  • シロリムス
  • 市場規模の推移・予測:エンドユーザー別
  • 病院
  • 心臓カテーテル検査室
  • 外来手術センター
  • 市場規模の推移・予測:末梢動脈疾患用薬剤コーティングバルーンのサブタイプ別
  • パクリタキセルコーティングバルーン
  • シロリムスコーティングバルーン
  • 市場規模の推移・予測:CAD用薬剤コーティングバルーンのサブタイプ別
  • パクリタキセルコーティングバルーン
  • シロリムスコーティングバルーン
  • エベロリムスコーティングバルーン
  • 市場規模の推移・予測:その他の適応症向け薬剤コーティングバルーンのサブタイプ別
  • 大腿膝窩動脈病変に対する薬剤コーティングバルーン
  • 腎動脈病変に対する薬剤コーティングバルーン
  • その他の血管用途向け薬剤コーティングバルーン

第7章 薬剤コーティングバルーン市場:地域・国別分析

  • 市場規模の推移・予測:地域別
  • 市場規模の推移・予測:国別

第8章 アジア太平洋の薬剤コーティングバルーン市場

第9章 中国の薬剤コーティングバルーン市場

第10章 インドの薬剤コーティングバルーン市場

第11章 日本の薬剤コーティングバルーン市場

第12章 オーストラリアの薬剤コーティングバルーン市場

第13章 インドネシアの薬剤コーティングバルーン市場

第14章 韓国の薬剤コーティングバルーン市場

第15章 西欧の薬剤コーティングバルーン市場

第16章 英国の薬剤コーティングバルーン市場

第17章 ドイツの薬剤コーティングバルーン市場

第18章 フランスの薬剤コーティングバルーン市場

第19章 イタリアの薬剤コーティングバルーン市場

第20章 スペインの薬剤コーティング風船市場

第21章 東欧の薬剤コーティングバルーン市場

第22章 ロシアの薬剤コーティング風船市場

第23章 北米の薬剤コーティングバルーン市場

第24章 米国の薬剤コーティングバルーン市場

第25章 カナダの薬剤コーティングバルーン市場

第26章 南米の薬剤コーティングバルーン市場

第27章 ブラジルの薬剤コーティングバルーン市場

第28章 中東の薬剤コーティングバルーン市場

第29章 アフリカの薬剤コーティングバルーン市場

第30章 薬剤コーティングバルーン市場:競合情勢と企業プロファイル

  • 競合情勢
  • 企業プロファイル
    • Acotec Scientific AG
    • B. Braun Melsungen AG
    • Biosensors International Group Ltd
    • Medtronic Inc.
    • Boston Scientific Corporation

第31章 薬剤コーティングバルーン市場:その他の大手および革新的企業

  • Opto Circuits
  • Concept Medical
  • Cardionovum GmbH
  • Endocor GmbH
  • Hexacath Sverige
  • iVascular SLU
  • Minvasys SAS
  • MedAlliance
  • QT Vascular Ltd
  • Terumo Corporation
  • Biotronik
  • Cook Medical
  • Cordis Corporation
  • Abbott Laboratories
  • Surmodics Inc.

第32章 世界の薬剤コーティングバルーン市場:競合ベンチマーキングとダッシュボード

第33章 薬剤コーティングバルーン市場:主要M&A

第34章 薬剤コーティングバルーン市場:最近の動向

第35章 薬剤コーティングバルーン市場:潜在性の高い国・セグメント・戦略

  • 最も新しい機会を提供する国
  • 最も新しい機会を提供するセグメント
  • 成長戦略

第36章 付録

目次
Product Code: r24098

A drug-coated balloon (DCB) is a medical device employed in the intervention of narrowed or obstructed blood vessels, particularly in interventional cardiology and interventional radiology. Its design facilitates the direct delivery of medication to the site of vascular disease while concurrently performing angioplasty.

The primary categories of products encompassed within drug-coated balloons include those tailored for peripheral artery disease, coronary artery disease, and other indications. Drug-coated balloons (DCBs) for peripheral artery disease are a specific type of medical device utilized in addressing peripheral artery disease (PAD). PAD is characterized by the narrowing or blockage of blood vessels outside the heart or in the lower extremities. Various drug types, such as paclitaxel and sirolimus, are employed, and the end-users encompass hospitals, cardiac catheterization labs, and ambulatory surgical centers.

The drug-coated balloons market research report is one of a series of new reports from The Business Research Company that provides drug-coated balloons market statistics, including drug-coated balloons industry global market size, regional shares, competitors with a drug-coated balloons market share, detailed drug-coated balloons market segments, market trends and opportunities, and any further data you may need to thrive in the drug-coated balloons industry. This drug-coated balloons market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug-coated balloons market size has grown rapidly in recent years. It will grow from$1.08 billion in 2024 to $1.24 billion in 2025 at a compound annual growth rate (CAGR) of 15.4%. The growth in the historic period can be attributed to increased cardiovascular disease burden, demand for minimally invasive procedures, prevalence of peripheral artery disease (pad), reducing restenosis rates, advancements in interventional cardiology

The drug-coated balloons market size is expected to see rapid growth in the next few years. It will grow to $2.22 billion in 2029 at a compound annual growth rate (CAGR) of 15.6%. The growth in the forecast period can be attributed to increasing aging population, expansion of indications and applications, focus on outpatient and ambulatory care, integration with drug delivery innovations, global health initiatives. Major trends in the forecast period include regulatory approvals for new formulations, focus on minimizing side effects, emergence of bioresorbable coatings, market expansion in emerging economies, patient-centric approaches.

The increasing prevalence of coronary artery disease (CAD) is projected to drive the growth of the drug-coated balloons market in the future. CAD is a medical condition characterized by the narrowing or blockage of the coronary arteries that supply blood to the heart muscle, often leading to heart attacks. Drug-coated balloons are medical devices used to treat coronary artery disease, releasing medication into the artery during the procedure to help prevent restenosis, which is the re-narrowing of the artery following angioplasty. For instance, a study published in the Journal of the American College of Cardiology in August 2022 indicated that all four cardiovascular risk factors are expected to rise among the general U.S. population from 2025 to 2060. Diabetes is projected to see the most significant increase at 39.3%, followed by dyslipidemia at 27.6%, hypertension at 25.1%, and obesity at 18.3%. Additionally, the researchers found that rates of heart failure (33.4%) and ischemic heart disease (30.7%) are expected to experience the largest increases, along with heart attacks (16.9%) and strokes (33.8%). Consequently, the rise in coronary artery disease prevalence is anticipated to boost the drug-coated balloon market.

The increasing number of ambulatory surgery centers is anticipated to propel the growth of the drug-coated balloon market. Ambulatory Surgical Centers (ASCs) are medical facilities dedicated to conducting surgical procedures that do not necessitate an overnight hospital stay. Drug-coated balloons play a crucial role in ASCs by offering shorter procedure times compared to standard balloons, resulting in improved patient throughput and reduced operational costs. For instance, VMG Health reported in September 2023 that the total number of Medicare-certified ambulatory surgery centers increased by 2.9% from 1752 in 2021 to 1804 in 2022. Hence, the growing prevalence of ambulatory surgery centers is a driving force behind the drug-coated balloon market's expansion.

Product innovations are emerging as a significant trend in the drug-coated balloon market. Leading companies in this sector are concentrating on developing new technological and innovative solutions to enhance their market position. For example, in August 2022, Becton, Dickinson, and Company (BD), a U.S.-based medical technology firm, initiated the PREVISION first-in-human trial for a peripheral sirolimus drug-coated balloon (DCB). This trial is designed to evaluate the safety and effectiveness of the sirolimus DCB for treating patients with peripheral artery disease, a condition that greatly affects mobility and quality of life.

Leading companies in the drug-coated balloon sector are dedicated to advancing their technologies, including paclitaxel-coated balloon catheters, to improve treatment efficacy for conditions such as coronary in-stent restenosis. These advancements aim to enhance patient outcomes and minimize the risk of complications associated with traditional therapies. Paclitaxel-coated balloon catheters are specialized devices that release the drug paclitaxel into the artery wall upon inflation, helping to prevent re-narrowing after angioplasty. For instance, in March 2024, Boston Scientific Corporation, a U.S.-based medical device manufacturer, received approval from the U.S. Food and Drug Administration (FDA) for its AGENT(TM) Drug-Coated Balloon (DCB). This device is designed specifically for treating coronary in-stent restenosis (ISR) in patients with coronary artery disease, which occurs when a previously stented blood vessel becomes obstructed or narrowed due to plaque or scar tissue.

In November 2022, Cordis, a US-based manufacturer of interventional cardiovascular technologies, completed the acquisition of Med Alliance SA for $1.1 billion. Through this acquisition, Cordis aims to globally provide the drug-eluting balloon SELUTION SLRTM (Sustained Limus Release) to two million patients by 2027. Med Alliance SA, based in Switzerland, is a developer of the sirolimus micro-reservoir drug-coated balloon.

Major companies operating in the drug-coated balloons market include Acotec Scientific AG, B. Braun Melsungen AG, Biosensors International Group Ltd, Medtronic Inc., Boston Scientific Corporation, Opto Circuits, Concept Medical, Cardionovum GmbH, Endocor GmbH, Hexacath Sverige, iVascular SLU, Minvasys SAS, MedAlliance, QT Vascular Ltd, Terumo Corporation, Biotronik, Cook Medical, Cordis Corporation, Abbott Laboratories, Surmodics Inc., Hexacath SAS, MicroPort, SurModics Inc., Orchestra BioMed

North America was the largest region in the global drug-coated balloons market in 2024, and is expected to be the fastest-growing region in the forecast period. The regions covered in the drug-coated balloons market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the drug-coated balloons market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The drug-coated balloons market consists of sales of everolimus and zotarolimus drug-coated balloons. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug-Coated Balloons Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drug-coated balloons market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug-coated balloons ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The drug-coated balloons market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Drug-Coated Balloons For Peripheral Artery Disease; Drug-Coated Balloons For Coronary Artery Disease; Drug-Coated Balloons For Other Indications
  • 2) By Drug Type: Paclitaxel; Sirolimus
  • 3) By End User: Hospitals; Cardiac Catheterization Labs; Ambulatory Surgical Centers
  • Subsegments:
  • 1) By Drug-Coated Balloons For Peripheral Artery Disease: Paclitaxel-Coated Balloons; Sirolimus-Coated Balloons
  • 2) By Drug-Coated Balloons For Coronary Artery Disease: Paclitaxel-Coated Balloons; Sirolimus-Coated Balloons; Everolimus-Coated Balloons
  • 3) By Drug-Coated Balloons For Other Indications: Drug-Coated Balloons For Femoropopliteal Lesions; Drug-Coated Balloons For Renal Artery Lesions; Drug-Coated Balloons For Other Vascular Applications
  • Companies Mentioned: Acotec Scientific AG; B. Braun Melsungen AG; Biosensors International Group Ltd; Medtronic Inc.; Boston Scientific Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Drug-Coated Balloons Market Characteristics

3. Drug-Coated Balloons Market Trends And Strategies

4. Drug-Coated Balloons Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Drug-Coated Balloons Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Drug-Coated Balloons PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Drug-Coated Balloons Market Growth Rate Analysis
  • 5.4. Global Drug-Coated Balloons Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Drug-Coated Balloons Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Drug-Coated Balloons Total Addressable Market (TAM)

6. Drug-Coated Balloons Market Segmentation

  • 6.1. Global Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug-Coated Balloons For Peripheral Artery Disease
  • Drug-Coated Balloons For Coronary Artery Disease
  • Drug-Coated Balloons For Other Indications
  • 6.2. Global Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Paclitaxel
  • Sirolimus
  • 6.3. Global Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Cardiac Catheterization Labs
  • Ambulatory Surgical Centers
  • 6.4. Global Drug-Coated Balloons Market, Sub-Segmentation Of Drug-Coated Balloons For Peripheral Artery Disease, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Paclitaxel-Coated Balloons
  • Sirolimus-Coated Balloons
  • 6.5. Global Drug-Coated Balloons Market, Sub-Segmentation Of Drug-Coated Balloons For Coronary Artery Disease, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Paclitaxel-Coated Balloons
  • Sirolimus-Coated Balloons
  • Everolimus-Coated Balloons
  • 6.6. Global Drug-Coated Balloons Market, Sub-Segmentation Of Drug-Coated Balloons For Other Indications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug-Coated Balloons For Femoropopliteal Lesions
  • Drug-Coated Balloons For Renal Artery Lesions
  • Drug-Coated Balloons For Other Vascular Applications

7. Drug-Coated Balloons Market Regional And Country Analysis

  • 7.1. Global Drug-Coated Balloons Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Drug-Coated Balloons Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Drug-Coated Balloons Market

  • 8.1. Asia-Pacific Drug-Coated Balloons Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Drug-Coated Balloons Market

  • 9.1. China Drug-Coated Balloons Market Overview
  • 9.2. China Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Drug-Coated Balloons Market

  • 10.1. India Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Drug-Coated Balloons Market

  • 11.1. Japan Drug-Coated Balloons Market Overview
  • 11.2. Japan Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Drug-Coated Balloons Market

  • 12.1. Australia Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Drug-Coated Balloons Market

  • 13.1. Indonesia Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Drug-Coated Balloons Market

  • 14.1. South Korea Drug-Coated Balloons Market Overview
  • 14.2. South Korea Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Drug-Coated Balloons Market

  • 15.1. Western Europe Drug-Coated Balloons Market Overview
  • 15.2. Western Europe Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Drug-Coated Balloons Market

  • 16.1. UK Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Drug-Coated Balloons Market

  • 17.1. Germany Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Drug-Coated Balloons Market

  • 18.1. France Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Drug-Coated Balloons Market

  • 19.1. Italy Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Drug-Coated Balloons Market

  • 20.1. Spain Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Drug-Coated Balloons Market

  • 21.1. Eastern Europe Drug-Coated Balloons Market Overview
  • 21.2. Eastern Europe Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Drug-Coated Balloons Market

  • 22.1. Russia Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Drug-Coated Balloons Market

  • 23.1. North America Drug-Coated Balloons Market Overview
  • 23.2. North America Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Drug-Coated Balloons Market

  • 24.1. USA Drug-Coated Balloons Market Overview
  • 24.2. USA Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Drug-Coated Balloons Market

  • 25.1. Canada Drug-Coated Balloons Market Overview
  • 25.2. Canada Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Drug-Coated Balloons Market

  • 26.1. South America Drug-Coated Balloons Market Overview
  • 26.2. South America Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Drug-Coated Balloons Market

  • 27.1. Brazil Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Drug-Coated Balloons Market

  • 28.1. Middle East Drug-Coated Balloons Market Overview
  • 28.2. Middle East Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Drug-Coated Balloons Market

  • 29.1. Africa Drug-Coated Balloons Market Overview
  • 29.2. Africa Drug-Coated Balloons Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Drug-Coated Balloons Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Drug-Coated Balloons Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Drug-Coated Balloons Market Competitive Landscape And Company Profiles

  • 30.1. Drug-Coated Balloons Market Competitive Landscape
  • 30.2. Drug-Coated Balloons Market Company Profiles
    • 30.2.1. Acotec Scientific AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Biosensors International Group Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Medtronic Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Drug-Coated Balloons Market Other Major And Innovative Companies

  • 31.1. Opto Circuits
  • 31.2. Concept Medical
  • 31.3. Cardionovum GmbH
  • 31.4. Endocor GmbH
  • 31.5. Hexacath Sverige
  • 31.6. iVascular SLU
  • 31.7. Minvasys SAS
  • 31.8. MedAlliance
  • 31.9. QT Vascular Ltd
  • 31.10. Terumo Corporation
  • 31.11. Biotronik
  • 31.12. Cook Medical
  • 31.13. Cordis Corporation
  • 31.14. Abbott Laboratories
  • 31.15. Surmodics Inc.

32. Global Drug-Coated Balloons Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Drug-Coated Balloons Market

34. Recent Developments In The Drug-Coated Balloons Market

35. Drug-Coated Balloons Market High Potential Countries, Segments and Strategies

  • 35.1 Drug-Coated Balloons Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Drug-Coated Balloons Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Drug-Coated Balloons Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer